impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Reviews

 

Aberrant glycosylation in autoimmune disease

1, 2, 3, 4, 5, 6

 

  1. Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  2. Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  3. Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences; National Clinical Research Center for Immunologic Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
  4. Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences; National Clinical Research Center for Immunologic Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
  5. Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. wangjian0771@163.com
  6. Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences; National Clinical Research Center for Immunologic Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China. huchaojun818@qq.com

CER12468
2020 Vol.38, N°4
PI 0767, PF 0775
Reviews

Free to view
(click on article PDF icon to read the article)

PMID: 31694739 [PubMed]

Received: 31/05/2019
Accepted : 06/08/2019
In Press: 22/10/2019
Published: 28/07/2020

Abstract

Autoimmune diseases (AIDs) result in high levels of various autoantibodies in the serum as well as systemic inflammation and targeted organ damage. The incidence of AID has increased over recent decades. Glycosylation is a significant part of the post-translational modification of proteins and has been recognised as an important part of immune regulation in humans. Aberrant glycosylation manifests as pro- or anti-inflammatory effects. Numerous studies have confirmed that aberrant glycosylation plays a crucial role in the AID process. The development of emerging technologies such as the lectin microarray has facilitated research on the structure and function of glycans and glycosylation. Newly developed devices allow for high-throughput, high-speed, and highly specific research on aberrant glycosylation. Here, we review the role of glycosylation in the regulation of effector function in the context of autoimmunity and aberrant glycosylation in AIDs. This paper also discusses emerging technologies and clinical applications of glycosylation.

Rheumatology Article